Search results

560 results

Sorted by Relevance . Sort by Date

  1. Inotersen for treating hereditary transthyretin amyloidosis (HST9)

    Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis

  2. Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)

    Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia (XLH) in children and young people

  3. Asfotase alfa for treating paediatric-onset hypophosphatasia (HST6)

    Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in adults and children

  4. Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)

    Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 in children

  5. Mental wellbeing at work

    In development [GID-NG10140] Expected publication date: 15 December 2021

  6. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (NG163)

    The purpose of this guideline is to provide recommendations for managing COVID-19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection.

  7. Postnatal care

    In development [GID-NG10070] Expected publication date: 07 April 2021

  8. Acute coronary syndromes

    In development [GID-NG10085] Expected publication date: 18 November 2020

  9. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

  10. Antenatal care

    In development [GID-NG10096] Expected publication date: 11 August 2021

  11. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 09 June 2021